The number of neurons in the mammalian brain is determined by a balance between cell proliferation and programmed cell death. Recent studies indicated that Bcl-XL prevents, whereas Caspase-3 mediates, cell death in the developing nervous system, but whether Bcl-X L directly blocks the apoptotic function of Caspase-3 in vivo is not known. To examine this question, we generated bcl-x͞caspase-3 double mutants and found that caspase-3 deficiency abrogated the increased apoptosis of postmitotic neurons but not the increased hematopoietic cell death and embryonic lethality caused by the bcl-x mutation. In contrast, caspase-3, but not bcl-x, deficiency changed the normal incidence of neuronal progenitor cell apoptosis, consistent with the lack of expression of Bcl-X L in the proliferative population of the embryonic cortex. Thus, although Caspase-3 is epistatically downstream to Bcl-XL in postmitotic neurons, it independently regulates apoptosis of neuronal founder cells. Taken together, these results establish a role of programmed cell death in regulating the size of progenitor population in the central nervous system, a function that is distinct from the classic role of cell death in matching postmitotic neuronal population with postsynaptic targets. P rogrammed cell death (apoptosis) is an important mechanism in mammalian nervous system development (1, 2). First, programmed cell death adjusts postmitotic neuron number to match the size of their peripheral targets (3). Second, early brain-region-specific apoptosis such as cell death in the lateral edges of the hindbrain neural fold is essential for normal neural tube closure (4). Finally, the incidence of apoptosis within the proliferative ventricular zones (VZ) suggests a potential role of programmed cell death in regulating the size of the progenitor pool (5). Given its importance in normal brain development, the mechanism of apoptosis has been a subject of active investigation.
P
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Recent gene-targeting studies identified Bcl-X L as a critical antiapoptotic factor and Bax, Apaf-1, Caspase-9, and Caspase-3 as key proapoptotic molecules during normal brain development (6) (7) (8) (9) (10) (11) (12) . Mice lacking bcl-x die as embryos and experience massive death of hematopoietic cells and postmitotic neurons (6) . In addition, Bcl-X L -deficient neurons are markedly susceptible to trophic factor withdrawal in vitro (13) . In contrast, mice lacking Bax show decreased cell death without obvious malformations (14) , whereas targeted disruptions of apaf-1, caspase-9, or caspase-3 lead to decreased neuronal apoptosis in the embryonic nervous system and gross structural abnormalities (8) (9) (10) (11) (12) .
In the nematode Caenorhabditis elegans, the homologues of Bax (EGL-1), Bcl-X L (CED-9), Apaf-1 (CED-4), and caspases (CED-3) have analogous effects on programmed cell death and form a linear cell death pathway (15) . Thus, it is an intriguing possibility that Bax, Bcl-X L , Apaf-1, Caspase-9, and Caspase-3 constitute an evolutionary conserved cell death pathway during brain development in mammals. Consistent with this hypothesis, it has been shown that bax deficiency prevents the increased cell death of immature neurons caused by the bcl-x mutation (16) . Furthermore, null mutations of either apaf-1 or caspase-9 disrupt the activation of Caspase-3, indicating a linear epistatic relationship in vivo (8, 10) . However, it remains unclear whether the antiapoptotic function of Bcl-X L is mediated specifically through inhibition of the proapoptotic effects of Caspase-3.
To test this hypothesis directly, we introduced the caspase-3 mutation into bcl-x-deficient mice to determine whether the (downstream) Caspase-3 deficiency would abolish the phenotypes of the (upstream) Bcl-X L deficiency, as predicted by an epistatic relationship of these two molecules similar to their counterparts in C. elegans (17) . In addition, we compared the embryonic expression pattern and null-mutation phenotypes of Bax, Bcl-X L , and Caspase-3. Our results indicate that, although Caspase-3 is epistatically downstream to Bcl-X L in postmitotic neurons, it has a unique effect on apoptosis of neuronal founder cells and is therefore pivotal for normal brain formation.
Materials and Methods
Generation of bcl-x͞caspase-3 Mutant Mice. To generate mice deficient in both Bcl-X L and Caspase-3, double heterozygote (bcl-x ϩ͞Ϫ ͞caspase-3 ϩ͞Ϫ ) mice were bred to produce embryos of nine possible genotypes, including bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ embryos. Endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts as described (6, 12) . To determine whether the distribution of generated genotypes followed the predicted Mendelian distribution, 2 analysis of contingency tables was used.
Quantification of Terminal Deoxynucleotidyltransferase-Mediated UTP End Labeling (TUNEL)-Positive Cells in Embryonic Day (E)12.5
Embryos. To detect DNA fragmentation during apoptosis, E12.5 embryos fixed in Bouin's fixative were cryoprotected in 30% (vol͞vol) sucrose, frozen, and sectioned horizontally. Frozen 20-m horizontal brain sections were incubated in 0.26 units͞ml terminal deoxynucleotidyltransferase, 1ϫ supplied buffer (Life Technologies), and 20 M biotinylated-16-dUTP (Roche Molecular Biochemicals) for 60 min at 37°C. The sections were then rinsed, blocked with 2% (vol͞vol) BSA in PBS (pH 7.4), and incubated with FITC-coupled streptavidin (Jackson ImmunoResearch; 1:100) in PBS.
Primary Telencephalic Culture. E12.5 telencephalic cells cultured in DMEM containing 1% FCS were incubated in 5% CO 2 at 37°C for 48 h as described (13) . Propidium iodide was added to label dead cells, and cultures were fixed with Bouin's fixative for 20 min at 4°C. The numbers of total nuclei and propidium iodide Abbreviations: TUNEL, terminal deoxynucleotidyltransferase-mediated UTP end labeling; En, embryonic day n; PP, preplate region; VZ, ventricular zone; MZ, marginal zone; FB, forebrain. *K.A.R. and C.-Y.K. contributed equally to this work. ‡ To whom reprint requests should be addressed. E-mail: kroth@pathology.wustl.edu or pasko.rakic@yale.edu.
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positive nuclei were counted at ϫ40 magnification from multiple randomly selected fields. Typically, between 150 and 200 nuclei were counted per well, and all conditions were performed in duplicate. Data from cultures were compared as percentages of total nuclei to control for slight differences in plating densities between embryos. Significance was established by using the nonparametric Kruskal-Wallis ANOVA on ranks and the MannWhitney rank sum test.
Histology and Immunocytochemistry. For semithin sections, 2% (vol͞vol) glutaraldehyde-fixed embryos were embedded in plastic, and serial 1-m sections were cut by a microtome. Of every 30 sections, 1 was collected and stained with 1% toluidine blue for detection of pyknotic nuclei. For immunocytochemistry, embryos were placed in Bouin's fixative overnight at 4°C, washed several times with 70% (vol͞vol) ethanol, embedded in paraffin, and cut in 4-m sagittal sections to be immunolabeled with antibodies to activated Caspase-3, MAP2, and Bcl-X L by using described methods (18) (19) (20) (21) (22) . Activated Caspase-3 was detected with an affinity-purified rabbit polyclonal antiserum, CM1, which recognizes the p18 subunit of cleaved Caspase-3 (18) . Bcl-X L immunoreactivity was detected with a mouse anti-Bcl-X L monoclonal antibody (H5, Santa Cruz Biotechnology), and MAP2 immunoreactivity was detected with a monoclonal antibody (Sigma). The specificity of the H5 antibody was established, because no cross immunoreactivity was found in the bcl-xdeficient embryos. Activated Caspase-3, MAP2, and Bcl-X L were detected with either fluorophore-conjugated secondary antibodies or the sequential tyramide signal amplification immunofluorescence methods (19) (20) (21) (22) . Tissue was counterstained with bisbenzimide and visualized on a Zeiss-Axioskop microscope equipped with epifluorescence. 
Results

Caspase-3 and Bcl-XL Have Distinct Expression Patterns in Early
Embryonic Brain. A ribonuclease protection assay was used to examine the expression of the caspase and Bcl-2 family genes during embryonic development of the mouse cerebrum. Expression of transcripts of caspase-3, bcl-x, and bax was detected as early as E11 until postnatal day 1 ( Fig. 1 a and b) . In addition to caspase-3, other effector caspases (caspase-6, caspase-7, and caspase-2) were also copiously expressed in the embryonic cerebrum throughout development.
Immunohistochemistry was used to localize the expression of Bcl-X L and activated Caspase-3 in the mouse embryonic telencephalon. The expression of Bcl-X L was found to be excluded from the proliferating population situated in the VZ but colocalized with a differentiated neuron marker (MAP2) in the PP of the E12.5 developing cerebrum ( Fig. 1 c and d) . In contrast, the activation of Caspase-3 was detected throughout the neuroepithelial wall including the proliferative VZ as early as E10.5 as seen by CM1 immunoreactivity (Fig. 1e) , an antibody that recognizes the cleaved p18 fragment but not the 32-kDa proenzyme of Caspase-3 (18) . In addition, the CM1 immunoreactivity was found greatly increased in specific brain regions, such as the laminal terminalia, characterized by high incidences of pyknotic clusters of dying cells (Fig. 1f ) . These results suggest that Caspase-3 may be involved in the apoptosis of neuronal founder cells and brain-region specific apoptosis, whereas Bcl-X L is not.
Phenotypic Comparison Suggests That Caspase-3 Has a Unique Effect on Apoptosis of Neuronal Founder Cells Independent of the Functions
of Bax and Bcl-XL. The functions of Caspase-3, Bax, and Bcl-X L in brain development were examined further and compared in E10.5 to E12.5 mutant embryos. In E12.5 wild-type embryos, clusters of pyknotic cells were confined to specific brain regions such as the lamina terminalis (Fig. 2a) where intense CM1 immunoreactivity was also detected (Fig. 1f ) . Except for these specific brain regions, the developing neuroepithelial wall in wild-type embryos was largely devoid of pyknotic cells (Fig. 2b) . In contrast, E12.5 bcl-x-deficient embryos had not only cell deaths in the laminal terminalis (data not shown) but also numerous ectopic pyknotic clusters in the MZ of the embryonic cerebrum where postmitotic neurons were located (Fig. 2c) .
If Bax and Caspase-3 are both proapoptotic in an obligate, epistatic cell death pathway, the phenotype of bax deficiency should be identical to that of caspase-3 deficiency. However, detailed analysis of mutant embryos revealed significant differences between the phenotypes of bax-and caspase-3-deficient embryos. The caspase-3 deficiency caused the absence of apoptosis in the laminal terminalis (Fig. 2d) and marked hyperplasia of the embryonic nervous tissue (Fig. 2f ) . In contrast, brainregion-specific apoptosis was surprisingly preserved in the baxdeficient mutants (Fig. 2g) . Moreover, there were no signs of hyperplasia or malformations of the nervous system in the bax-deficient embryos (Fig. 2h) .
The effect of caspase-3 deficiency on the apoptosis of postmitotic neurons was also examined by comparing TUNEL staining in the E12.5 telencephalon of caspase-3-deficient embryos with their wild-type littermates. The TUNEL assay revealed an uneven distribution of apoptotic cells in the embryonic telencephalon; TUNEL-positive cells were densely located within the lamina terminalis (24.07 Ϯ 3.49; mean Ϯ SEM; Fig.  3 a and c) and were correlated with high incidences of pyknotic cells observed in semithin sections (compare Fig. 2a ). In contrast, only 18.3 Ϯ 0.82 labeled cells per section were scattered throughout the rest of the FB (Fig. 3 b and c) . 
Caspase-3 Deficiency Does Not Prevent Increased Hematopoietic Cell
Apoptosis or Embryonic Lethality in Bcl-XL-Deficient Mice. To test directly the interaction between Caspase-3 and Bcl-X L in development, we crossed heterozygous bcl-x and caspase-3 mutant mice to generate bcl-x and caspase-3 double-deficient animals. Genotypic analysis of 72 live-born pups derived from interbreeding of bcl-x ϩ͞Ϫ ͞caspase-3 ϩ͞Ϫ mice revealed no bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ animals. In contrast, embryos harvested at E12.5, before the lethal effect of Bcl-X L deficiency, had the expected ratio of genotype distribution according to Mendelian heredity ( Table 1) . The bcl-x deficiency results in embryonic lethality caused by increased apoptosis in the developing hematopoietic and͞or hepatocellular system at ϷE13.5 (6). To determine the cause of embryonic lethality of the double mutants, the livers of E12.5 wild-type, bcl-x-deficient, caspase-3-deficient, and doubledeficient embryos were examined by the TUNEL method and CM1 immunoreactivity. An Ϸ3-fold increase of TUNELpositive cells was observed in the bcl-x-deficient liver, which was not reduced in the bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ mutants (Table 2) . Importantly, only rare CM1 immunoreactive cells were detected in the wild-type liver, which were not increased in the bcl-xdeficient liver (Table 2 ). This finding suggests that Bcl-X L normally prevents a Caspase-3-independent apoptotic pathway in the developing hematopoietic system, the unchecked regulation of which is responsible for embryonic lethality of the bcl-x-deficient and bcl-x͞caspase-3 double-mutant embryos.
Caspase-3 Deficiency Abrogates Increased Apoptosis Caused by the
Bcl-X L Mutation Both in Vivo and in Vitro. Histological examination of the double mutants, however, indicates that the Caspase-3 deficiency is sufficient to eliminate virtually all ectopic apoptosis caused by the bcl-x mutation in the nervous system. The E12.5 bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ double mutants had gross brain malformations such as hindbrain exencephaly (Fig. 2i) previously reported in the caspase-3 and caspase-9 null mutations (10) (11) (12) . In addition, the ectopic pyknotic clusters in the developing cerebrum caused by the Bcl-X L deficiency were totally prevented by the additional Caspase-3 deficiency (Fig. 2f ) .
Similarly, although bcl-x-deficient embryos showed a marked increase of apoptotic cells in the spinal cord as compared with wild-type mice (Fig. 4a) , this aberrant neuronal apoptosis was rescued by the additional caspase-3 deficiency in the double mutants (Fig. 4b) . The suppression of cell death in the doublemutant spinal cord correlated with an absence of activated Caspase-3-positive cells (Fig. 4 c and d) . Furthermore, quantitative analysis of TUNEL-positive and CM1-immunoreactive cells in the dorsal root ganglia indicated that both apoptosis and Caspase-3 activation are suppressed in the bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ mutants compared with bcl-x Ϫ͞Ϫ mutants ( Table 2) . Together, these results indicate that bcl-x deficiency causes apoptosis of postmitotic neurons primarily through uninhibited activation of Caspase-3 in vivo.
Primary telencephalic cell cultures were used to define further the interaction between Bcl-X L and Caspase-3 in postmitotic neurons, because Bcl-X L -deficient neurons are markedly susceptible to apoptosis in vitro (13) . Telencephalic cells isolated from E12.5 wild-type, bcl-x-deficient, caspase-3-deficient, and double-deficient embryos were grown for 48 h in DMEM TUNEL-and CM1-positive cells were quantified in multiple ϫ60 magnification fields of liver and dorsal root ganglia from each embryo. The mean number of positive cells and SEM per field were determined for each group. Significance was determined by using the nonparametric Kruskal-Wallis ANOVA on ranks. The numbers of embryos used for both TUNEL and CM1 immunoreactivity in each genotype are bcl-x ϩ͞* ͞casp3 ϩ͞* (23͞14); bcl-x Ϫ͞Ϫ ͞ casp3 ϩ͞* (10͞4); bcl-x ϩ͞* ͞casp3 Ϫ͞Ϫ (7͞4); and bcl-x Ϫ͞Ϫ (5͞4). ϩ͞* ͞casp3 Ϫ͞Ϫ includes both ϩ͞ϩ and ϩ͞Ϫ mice. † , P Ͻ 0.05 compared to bcl-x ϩ͞* ͞casp3 ϩ͞* mice.
containing 1% FCS and then stained with propidium iodide to identify nonviable cells. After fixation, CM1 immunocytochemistry was performed to detect Caspase-3 activation (Fig. 4e) . The Bcl-X L -deficient telencephalic neurons had increased Caspase-3 activation and greater cell death compared with wild-type neurons. However, double-mutant cells grown in DMEM with 1% FCS had reduced cell death correlated with little Caspase-3 activation (Fig. 4e) . Together, these in vitro results are consistent with the ability of caspase-3 deficiency to rescue bcl-x-deficient neurons from apoptotic cell death in vivo and further support an epistatic relationship between Bcl-X L and Caspase-3 in postmitotic neurons.
Discussion
Recent gene-targeting studies indicated that Bcl-X L prevents, whereas Bax and Caspase-3 promote, cell death in the developing nervous system (6, 12, 14) . It has been shown that bax deficiency prevents the increased cell death of postmitotic neurons in bcl-x-deficient embryos, suggesting an epistatic interaction between Bax and Bcl-X L in brain development (16) . In the present study, we examined the interaction between Bcl-X L and Caspase-3 by analyzing mice carrying targeted gene disruptions in one or both of these molecules. Our results indicate that Caspase-3 mediates apoptosis of both founder cells and postmitotic neurons, whereas Bcl-X L functions as an antiapoptotic factor exclusively in the postmitotic population. Importantly, the proapoptotic function of Caspase-3 in founder cells is unique and not shared by Bax. Moreover, the additional Caspase-3 deficiency abrogates the increased apoptosis of postmitotic neurons caused by the absence of Bcl-X L both in vivo and in vitro. These results provide definitive genetic evidence that, in postmitotic neurons in the developing mammalian nervous system, Bcl-X L and Caspase-3 form an obligate cell death pathway, similar to their homologues in the nematode C. elegans.
We propose a scheme to explain the interactions of Bax, Bcl-X L , and Caspase-3 during mammalian brain development (Fig. 5) . Bcl-X L inhibits the proapoptotic effect of Caspase-3 in the postmitotic neuronal population (Fig. 5, actions a and b) , and ] (e) Quantification of Caspase-3 activation and cell death in control, bcl-x Ϫ͞Ϫ , caspase-3 Ϫ͞Ϫ , and bcl-x Ϫ͞Ϫ ͞caspase-3 Ϫ͞Ϫ E12.5 telencephalic cells grown for 48 h in DMEM plus 1% FCS; Caspase-3 activation was detected with CM1 antiserum, and cell viability was determined by exclusion of propidium iodide. Bcl-X L-deficient cells had increased Caspase-3 activation and cell death; concomitant Caspase-3 deficiency inhibited the death-promoting effects of Bcl-X L deficiency in this in vitro paradigm. No effect of gene dosage on neuronal apoptosis was observed for either bcl-x or caspase-3, and therefore, data from wild-type and heterozygous mutants were pooled ( * denotes either ϩ or Ϫ ). #, P Ͻ 0.05 compared with bcl-x ϩ͞* ͞caspase-3 ϩ͞* cells.
therefore bcl-x deficiency causes increased apoptosis of postmitotic neurons (6), which is prevented by the additional absence of caspase-3. Bax seems to modulate the antiapoptotic effects of Bcl-X L (Fig. 5, action c) ; the null mutation of bax therefore reduces the normally occurring developmental death of postmitotic neurons without affecting the global formation of the nervous system (14) .
The distinguishing characteristic of Caspase-3 in this scheme is its dual functions in both postmitotic and neuronal progenitor apoptosis (Fig. 5, actions b and d) . Although caspase-3 deficiency results in decreased apoptosis of postmitotic neurons in the developing cortex, given the normal brain structures in baxdeficient mice, this effect is unlikely to be sufficient to cause gross malformations. Instead, the unique effect of caspases on progenitor cell apoptosis is critical for establishing the size of the neuronal founder pool (25) . Deficiency of Caspase-3 thus rescues a number of progenitor cells from programmed cell death, resulting in an exponential expansion of the progeny, ultimately leading to marked dysplasia and malformations of the nervous system. Therefore, these results suggest that programmed cell death is not only important for adjusting the final number of neurons to match their target fields but is also essential for establishing the initial size of the progenitor pool in the developing nervous system. 
